Free Trial

Novozymes A/S (OTCMKTS:NVZMY) Sees Unusually-High Trading Volume - Time to Buy?

Novozymes A/S logo with Basic Materials background

Key Points

  • Novozymes A/S experienced a significant increase in trading volume, with approximately 143,190 shares traded, marking a 263% rise from the previous session.
  • The company has been downgraded from a "strong-buy" to a "hold" rating by Zacks Research, impacting investor sentiment.
  • A dividend of $0.1856 per share is set to be paid on September 11th, with an ex-dividend date on September 2nd, reflecting a yield of 88.0%.
  • MarketBeat previews top five stocks to own in October.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 143,190 shares changed hands during mid-day trading, an increase of 263% from the previous session's volume of 39,453 shares.The stock last traded at $62.73 and had previously closed at $64.20.

Analyst Ratings Changes

Separately, Zacks Research downgraded shares of Novozymes A/S from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 25th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Novozymes A/S has an average rating of "Moderate Buy".

Get Our Latest Stock Report on NVZMY

Novozymes A/S Trading Down 2.2%

The company has a debt-to-equity ratio of 0.11, a current ratio of 1.66 and a quick ratio of 1.04. The company's fifty day moving average is $67.90 and its 200-day moving average is $65.32. The stock has a market cap of $29.39 billion, a PE ratio of 39.72, a PEG ratio of 1.26 and a beta of 0.93.

Novozymes A/S Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd will be issued a dividend of $0.1856 per share. This represents a dividend yield of 88.0%. The ex-dividend date of this dividend is Tuesday, September 2nd. Novozymes A/S's dividend payout ratio (DPR) is 48.10%.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.